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Background: Prediabetes and old age are both high risk factors for developing Type 2 Diabetes (T2D),
while obesity is one of the most important factors triggering the disease. Nutritional interventions are
the most effective tool for preventing T2D, as they improve different biochemical and anthropometric
outcomes and growth-promoting/inhibiting gut microbiota populations. However, to date there are no
specific dietary recommendations to stop the development of T2D in elderly groups, for whom hypo-
caloric diets and other commonly used weight-loss programs could be considered dangerous. The
objective of our study, thus, was to understand the impact of dietary patterns on T2D risk as related to
gut microbiota profile in obese and non-obese elderly prediabetic subjects.
Methods: A cross-sectional study was performed in 182 subjects 65 years old with prediabetes, divided
into obese (OB) or non-obese (NOB) subgroups, and their risk of developing T2D was measured according
to FINDRISK score and biochemical parameters. Also, clusters into different dietary patterns in each
group by PCA analysis was related with gut microbiota, which was analyzed from stool samples by qPCR.
The creation of clusters was used to re-evaluate T2D risk.
Results: OB was at higher risk of developing T2D and showed worse metabolic outcomes. Unhealthier
and healthier dietary pattern clusters were observed for both OB (OB-6 and OB-5 respectively) and NOB
(NOB-2 and NOB-3 respectively) groups. Results obtained from the gut microbiota showed that only
Prevotella was higher in NOB, but when comparisons were made between clusters, a clear relation with
dietary pattern was observed; showing in healthier dietary clusters a decrease in Prevotella, an increase
of Faecalibacterium prausnitzii and an increase in lactic acid bacteria. T2D risk was greater in the obese
group between unhealthier dietary clusters. No difference between healthier dietary clusters was
observed.
Conclusion: A healthy dietary pattern and the growth-promoting beneficial and growth-inhibiting
disadvantageous gut microbiota populations linked to it provide protection against the development
of T2D in an obese population with advanced age and preDM.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).esearch Laboratory, Institut
IBAPS) e Hospital Clinic of
is).
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Prediabetes (preDM) is defined as a state that precedes type 2
diabetes (T2D), which, together with its complications, is a major
cause of early death in most countries [1].
Moreover, preDM, characterized by fasting blood glucose levels
of 100e125 mg/dL [2], has been recognized as clinically relevant
due to its association with metabolic syndrome and cardiovascular
disease (CVD) [3]. Alongside T2D and obesity, preDM has become
prevalent worldwide [1]. The natural history of preDM predicts that
up to 70% of individuals with this condition will develop T2D, with
the annual conversion ratio in prediabetic population around 10%
[4,5]. However, the number of new-onset T2D in individuals 65
years old particularly stands out, increasing 4.5-fold as compared to
3-fold in total population [6].
The prevalence of T2D increases with age but also with the
presence of obesity [7], as the risk of developing T2D at 65 years old
increases >25% with a BMI 30 kg/m2 [8].
Clinical guidelines recommend weight loss for the prevention of
T2D through lifestyle modifications but fail to include specifications
for old age [2]. The effects of weight loss in the elderly have been
under debate, as some epidemiological studies have shown that it
leads to increased mortality [9,10]. This is probably due to the un-
intentional weight loss of concretely fat-free or lean mass loss that
also occurs [11], which is associated with various health problems.
Among these is increased insulin resistance [12] and, with it, an
increased risk of developing T2D.
Generally, nutritional interventions used for weight loss are
based on hypocaloric diets that can lead to malnutrition in the
elderly [13]. A more interesting intervention in this age group
would be one based on changing dietary patterns instead of
focusing on caloric restrictions, but first it is essential to know
which dietary patterns are present, information that is currently
missing for this population.
Meanwhile, in addition to the known effects that a specific diet
can produce on different clinical parameters such as glycaemia,
impact on gut microbiota has also been established. Diets provide a
range of growth-promoting and growth-inhibiting factors for spe-
cific bacterial phylotypes that ferment different substrates [14].
Unhealthy dietary habits have been found to produce dysbiosis,
which, in turn, can affect metabolism and increase susceptibility to
different diseases. Gut microbiota has been suggested to play an
important role in the development of T2D, in conjunction with or
independently of obesity [15].
We hypothesize that elderly obese-prediabetic subjects are at
higher risk of developing T2D than non-obese ones but that a
healthy diet will be linked to a better gut microbiota profile,
therefore, obese subjects who show beneficial dietary and gut
microbiota pattern will have a lower risk of developing T2D.2. Methods
This study was a cross-sectional study developed in three pri-
mary care centers in Barcelona (CAP Les Corts, Borrell and Casa-
nova) from 2014 to 2016.2.1. Participants
Subjects included, from whom informed consent was obtained
for experimentation and study was performed in accordance with
The Code of Ethics of the World Medical Association, were males
and females 65 years old with glucose levels between 100 and
125 mg/dL and without a previous diagnosis of diabetes. Subjects
were excluded from the study if they were taking antidiabeticdrugs or had previously received any nutritional education to
improve their blood glucose levels or were taking antibiotics.
Based on the clinical records of the primary care centers, a list of
929 patients who met the inclusion criteria was created. 403 were
contacted at random, of which 195 were cited for a screening
appointment. A final total of 182 subjects were selected for inclu-
sion in the study.
All participants provided written informed consent, and the
study protocol was approved by the Ethics Committee of Hospital
Clinic de Barcelona.
2.2. Measures
 Anthropometrics: Subjects were weighed and measured
without clothing and shoes. BMI was calculated as weight (kg)/
height (m)2, and waist circumference was measured at the
midpoint between the last rib and the iliac crest and hip
circumference at the widest point of the gluteus.
 Body composition was measured using Lunar iDXA body
composition (GE Healthcare) according to the standard oper-
ating protocol.
 Blood pressure was taken after individuals sat quietly for 5 min
in a clinical examination room. The mean of three different
measurements, obtained every 3 min using an OMRON M6 AC
sphygmomanometer, was recorded.
 Fasting blood samples were collected by a nurse from each
primary care center and were sent, refrigerated at 4 C, to the
central laboratory of Hospital Clinic i Provincial de Barcelona,
where they were analyzed by the Biomedical Diagnosis Centre
(CDB).
 T2D risk: The Finnish Diabetes Risk Score (FINDRISK) ques-
tionnaire was completed according of the creation groups of
“low”, “medium”, “high” and “very high” risk of developing T2D.
 Lifestyle habits: Physical activity was estimated using VREM, a
short questionnaire adapted from the Minnesota Leisure Time
Physical Activity Questionnaire for individuals of advanced age.
Nutritional patterns were measured using a 3-day dietary re-
cord revised corrected by a nutritionist and analyzed by the
DIAL nutritional calculation program.
 Gut microbiota: Genomic DNAwas extracted from fecal samples
using the PSP® Spin Stool DNA Plus kit (Stratec, Berlin, Ger-
many). Fecal samples were collected by the volunteers, imme-
diately frozen and bring to the laboratory in less than 4 hours
and were kept at 80C until analysis. Gut microbiota compo-
sition was determined by quantifying the abundance of target
bacterial indicators by quantitative PCR (qPCR), namely Firmi-
cutes, Bacteroidetes, Faecalibacterium prausnitzii (F. prausnitzii),
Escherichia coli (E. coli), Prevotella, and lactic acid bacteria. These
indicators were chosen based on previous association with T2D
or preDM. Total bacteria quantification was also performed in
order to calculate relative abundances of the indicators and to
normalize data. 16S rRNA targeted primers, probes, standards
for quantification (16S rRNA gene inserted in a pCR®4-TOPO®
cloning plasmid and linearized with NotI), and PCR conditions
are detailed in Supplementary Table S2. Standard curves, inhi-
bition controls and non-template controls were included in each
run, and samples were run in duplicate. A 7500 Real Time PCR
system was used for all quantifications. Data is given as the
Log10 of the ratio between 16S rRNA gene copies of the target
microorganism and total bacterial 16S rRNA genes detected in
the same sample.
 Statistical analysis: Descriptive data are presented as the mean
and standard deviation (SD) or median and interquartile
ranges (IQRs) for continuous outcomes, or number and per-
centage (%) for categorical outcomes. Non-parametric Mann-
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outcomes when normality and equality of variance could not
be assumed. Student's t test was used for the rest of continuous
outcomes and Chi-square test for categorical outcomes.
Nutrient pattern analysis was performed using Principal
Component Analysis (PCA) based on the intake of 169 nutrients
divided into monounsaturated, polyunsaturated, saturated
fatty acids, cholesterol and carbohydrates (starches and
sugars). In order to capture variability of nutrient intake
independently, two separate PCA were performed for obese
and non-obese subjects. False discovery rate (FDR) correction
was used for multiple comparisons. All significance tests were
2-tailed, and values of P < 0.05 were considered significant. All
analyses were conducted using the R V.3.0.3 for Windows
statistical software package.Table 1
Characteristics from each group.
NOB (n¼99)
Sex , % female 43.4
Age, year 71.15 (4.59)
Personal history
Evolution IFG, years 4.77 (3.36)
Family history DM, % cases 36.4
Hypertension, % cases 56.6
CVD, % cases 12.1
Dyslipidemia, % cases 63.6
Drugs
Antihypertension, % consumers 58.6
Antithrombotic, % consumers 21.2
Cholesterol-lowering drugs, % consumers 49.5
Gastric protector, % consumers 24.2
Thyroid hormone therapy, % consumers 8.1
Antidepressant, % consumers 16.2
Bronchodilators, % consumers 4
Opioid analgesics, % consumers 10.1
Other, % consumers 62.6
Toxic habits
Smoking, % cases 6.1
Previous smoking, % cases 52.5
Occasional drinking, % cases 58.8
Daily drinking, % cases 24.7
Blood pressure
Systolic blood pressure, mmHg 131.76 (16.32)
Dyastolic blood pressure, mmHg 77.98 (9.53)
Blood chemistry
HbA1c, % 6.02 (0.43)
Glucose, mg/dL 104.04 (12.76)
Insuline, mU/L 13.97 (5.92)
Total cholesterol, mg/dL 197.23 (34.11)
Cholesterol- HDL, mg/dL 49.94 (11.25)
Cholesterol-LDL, mg/dL 125.69 (29.4)
Tryglicerides, mg/dL 113.4 (60.12)
AdipoQ, mg/mL 10.89 (5.45)
Anthropometrics
Weight, kg 73.06 (9.92)
BMI, kg/m2 26.62 (2.06)
Waist, cm 95.2 (8.91)
Hips, cm 102.42 (5.78)
Percentage approximation ideal weight, % 120.63 (9)
Body composition NOB (n¼51)
Centile fat mass, index 85.25 (18.5)
Fat mass total, % 37.8 (5.05)
Fat mass total, gr 26263.12 (4691.
Fat mass, torso % 42.31 (4.87)
Fat mass in abdomen, % 47.68 (5.63)
Fat mass in hips, % 40.42 (7.93)
Lean mass, total % 56.69 (6.12)
Values are expressed as mean (SD) for quantitative data, and mean % of subjects for freq
No differences were observed in the general characteristics of the group in terms of ag
antithrombotics showed to be higher in the OB group. OB also demonstrated greater blo
torso and hips. Worse blood chemistry values were observed in OB, with higher HbA1c, g
diabetes mellitus, HbA1c¼standardized glycosylated hemoglobin NGS, AdipoQ¼ adipon3. Results
Our recruited subjects were 49.7% female and 50.3% male. Their
mean age was 71.5 ± 5.4 years, while the mean duration of PreDM
was 4.7 ± 3.4 years.
T2D risk was calculated, with 86.18% of subjects showing a
“high” or “very high” risk of developing the disease, according to
FINDRISK test. Since one of the most important risk factors was
body weight, participants were divided into two groups according
to whether they were obese (OB) or not (NOB), with 45.6% of them
presenting a BMI 30 kg/m2.
Clinical characteristics of both groups were similar, with the
exception of antithrombotic drug intake, which was more frequent
in the OB group, along with systolic (SBP) and diastolic (DBP) blood
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Fig. 1. Energy balance from each group comparing energy intake recorded from
dietary records and energy expended ,calculated taking into consideration basal
energy expenditure and physical activity. While no difference in energy intake was
observed, the NOB group expended more energy than OB. The difference between
energy expended and energy ingested was different in each group and also between
groups, being higher in OB. NOB¼ on-obese, OB¼obese.
Table 2
Nutrient intake differences between groups.
NOB (n¼86) OB (n¼64) P-value
Carbohydrates, kcal % diet 39.42 (6.61) 38.8 (6.42) 0.553
Simple sugar, gr 78.26 (27.67) 80.04 (29.65) 0.963
Starch, gr 86.53 (33) 87.11 (34.61) 0.967
Soluble fiber, gr 4.96 (1.92) 4.69 (1.98) 0.341
Insoluble fiber, gr 9.52 (4.15) 8.85 (3.77) 0.301
Lipids, kcal % diet 40.88 (5.99) 40.12 (6.02) 0.599
Cholesterol, gr 278.13 (148.15) 308.1 (115.51) 0.03
SFA, % 11.82 (2.49) 11.5 (2.6) 0.367
MUFA, % 19.3 (4.02) 19.43 (4.14) 0.527
PUFA, % 6.28 (1.79) 5.61 (1.42) 0.008
PUFA u6, gr 11.01 (5.04) 9.71 (4.06) 0.115
Linoleic acid C18:2, % 4.82 (1.49) 4.35 (1.3) 0.031
PUFA u3, gr 2.8 (1.61) 2.23 (1.26) 0.012
Linolenic acid C18:3, % 0.82 (0.43) 0.67 (0.28) 0.003
Proteins, kcal % diet 17.04 (2.97) 17.86 (3.24) 0.22
Proteins, gr/Kg weight 1.07 0.97 0.004
Values are expresses as mean (SD). Statistically significant differences are high-
lighted in boldface.
No differences were observed in the consumption of carbohydrates and total lipids.
Only for one of three macronutrients, OB showed a lower consumption of proteins
considering gr of protein/Kg of weight. The OB group also demonstrated a higher
intake of cholesterol and less PUFA, linoleic acid, PUFA w3 and linolenic acid. NOB¼
non-obese, OB¼obese, SFA¼ saturated fatty acids, MUFA¼ monounsaturated fatty
acids, PUFA¼polyunsaturated fatty acids, u6¼ omega 6, u3¼omega.
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and waist and hip circumference. Ideal weight was calculated by
Lorentz formula, and the percentage of approximation to it was
more distant for OB (Table 1).
Total fat amount and the accumulation of fat in different parts of
the body, as well as the centile in which they were classified, were
higher in the OB than in NOB group. On the other hand, OB showed
a lower percentage of lean mass (Table 1).
The mean of the percentage risk of developing diabetes ac-
cording to FINDRISK showed a significant difference (p < 0.001)
between groups: 40.17 ± 8.45 in the OB group and 32.40 ± 12.20 in
the NOB group. Specifically, the percentage of individuals classified
as having a “high” or “very high” risk of developing T2D was
different (p < 0.001): 100% of OB participants and 77.78% of NOB
participants.
OB was associated with significantly higher glucose, HbA1c and
insulin (Table 1). When homeostatic model assessment for insulin
resistance (HOMA-IR) was calculated, OB showed a higher index
than NOB (5.37 ± 2.73 and 3.68 ± 1.85 respectively, p < 0.001), and
for beta-cell function (HOMA-b), OB also showed a stronger
compensatory effect of pancreatic function than NOB
(155.06 ± 70.59 and 127.5 ± 45.81 respectively, p ¼ 0.003).
3.1. Lifestyle habits
The percentage of sedentariness, classified according FAO/WHO/
UNU [16], in the OB group was higher than in the NOB group, at
61.2% and 40.65%, respectively (p¼ 0.01). Moreover, OB expended a
lower energy expenditure practicing physical activity than the NOB
group, as calculated by METS (272.1 ± 184.7 and 330.2 ± 192.4
respectively, p ¼ 0.05) and by Kcal (721.7 ± 554.9 and 537.4 ± 386
respectively, p ¼ 0.02).
Harris-Bennedict formula was used to evaluate daily energy
expenditure with adjustments made for elderly and overweight or
obese conditions, as described previously [17]. Total daily energy
expenditurewas lower in OB as compared to NOB (1167.71 ± 201.62
and 1402.11 ± 187.50 respectively, p < 0.001).
Analyses of 3-day dietary records revealed that the energy
intake was similar in NOB and OB groups (1992.9 ± 564.6 and
1958.44 ± 503.9 Kcal/day, respectively), however, although both
groups ingested more Kcal than they expended per day, OB showed
a greater excess because their daily energy expenditure was lower
(Fig. 1).
As for total calories consumed (TCC), both groups followed a
diet rich in lipids (>35% of TCC) and poor in carbohydrates
(<45% of TCC). Although both groups consumed a low per-
centage of carbohydrates, they exceeded for the recommenda-
tion for simple sugars (>10% of TCC) [18,19]. Furthermore, in
terms of lipid consumption, both groups consumed an excess of
saturated fatty acids (SFA) (>7% of TCC) but a correct proportion
of unsaturated fatty acids (UFA) to polyunsaturated fatty acids
(PUFA) (<10% of TCC), and monounsaturated fatty acids (MUFA)
(10e20% of TCC) [2].
Differences between groups also appear in nutrient consump-
tion (Table 2). NOB showed a lower intake of cholesterol and a
higher intake of PUFA, especially omega 3 fatty acids (PUFA u3); in
particular, NOB consumed more linolenic acid but also more lino-
leic acid, an omega 6 fatty acid (PUFAu6). For their part, OB showed
less protein consumption (gr/Kg weight).
Other nutrients were considered in the analyses (data not
shown), revealing a better quality diet in NOB due to a higher
consumption of micronutrients with antioxidant properties, such
as phytosterols (p ¼ 0.038), available organic acid (p ¼ 0.011),
luteine (p ¼ 0.034), citric acid (p ¼ 0.015) and tocopherols
(p < 0.005).3.1.1. Clusters
Nutrient pattern analysis by means of PCA showed that partic-
ipants were distributed among six clusters (Supplementary
Figure S1).
From them, four different dietary patterns were clearly identi-
fied on the first principal planes (Fig. 2), with two different sub-
patterns observed in each group. NOB showed, on the one hand,
subpattern NOB-2, based on amino acids (A) and SFA andMUFA (B),
and, on the other, subpattern NOB-3 based on PUFA, in particular
PUFA u3 (C), antioxidant nutrients (D) and based on minerals and
purines (E). On the contrary, the OB group showed subpattern OB-5
based on foods rich in PUFA (F), vitamin B and some minerals (G),
antioxidant nutrients (H) and based on other minerals and purines
(I). The remaining subpattern of this group, OB-6, was characterized



































































Fig. 2. PCA analysis of different nutrients found in each dietary pattern explaining the 30% of NOB and the 51% of OB in dimensions 1 and 2. NOB¼ on-obese, OB¼obese.
Groups of nutrients: A: Alanine, Serine, , Arginine, Glycine, Proline, Tyrosine, Histidine, Isoleucine, Lysine, Methionine, Threonine, Tryptophane, Phenylalanine, Leucine, Valine. B:
Palmitoleic C16:1, Palmitic C16:0, Oleic C18:1 cis 9, Lipids, MUFA, SFA. C: PUFA, PUFA u6, PUFA u3, Linoleic C18:2. D: Vegetable fiber, Vit. E, Vit. K, TRAP, Oxalic acid, Tocopherol total,
a - Tocopherol. E: Nickel, Chrome, Fluor, Magnesium, Potassium, Adenine, Guanine. F: Linolenic C18:3, PUFA u3. G: Calcium, Vit. B2, Iron. H: Vit K, TRAP, Oxalic acid, Vegetable fiber.
I: Nickel, Chrome, Fluor, Magnesium, Potassium, Adenine, Guanine. J:Alanine, Serine, , Arginine, Glycine, Proline, Tyrosine, Histidine, Isoleucine, Lysine, Methionine, Threonine,
Tryptophane, Phenylalanine, Leucine, Valine. K: Fiber, Insoluble fiber, Soluble fiber, Vit. E, Tocopherol total, a-Tocopherol, Folates. L: Vit. B1, Vit. B9, Vit. B7, Vit. B3, Coline. M: PUFA,
PUFA u6, Linoleic C18:2, SFA, Stearic C18:0, FA cis, Palmitoleic C16:1, Palmitic C16:0, Oleic C18:1 cis 9, Lipids, MUFA, SFA. N: Carbohidrates, Simple sugar.
D.A. Díaz-Rizzolo et al. / Clinical Nutrition 39 (2020) 524e532528vitamins (L), and PUFA, specifically omega 6, but also SFA andMUFA
(M) and carbohydrates, especially simple sugars (N). The two
remaining clusters (NOB-1 and OB-4), did not show any clear di-
etary pattern when focusing on 6 dimensions. Clusters NOB-3 and
OB-5 were similar in nutrient composition, while NOB-2 and OB-6
also showed very similar patterns.
3.2. Microbiota
Prevotella relative abundance was three times higher in NOB
than in OB subjects (p ¼ 0.047). No statistically significant differ-
ences were found in the abundance of the other bacterial groups
analyzed comparing obese and non-obese subjects (Supplementary
Table S1).
3.2.1. Clusters
Differences for microbiota population were observed according
to the four previously described clusters of dietary patterns
(Table 3).
When comparing these four clusters, no significant differences
were found. However, in NOB-2, Prevotella load tended to be higherTable 3
Comparison of microbiota populations between clusters selected in dietary patterns des
NOB -2 (n¼22) NOB -3 (n¼5) OB
Firmicutes 206 [126.7e370.2] 199.1 [34.33e210.1] 193
Bacteroidetes 42.17 [15.09e63.51] 54.06 [34.29e67.62] 26.3
Prevotella 2.261 [0.181e10.91] 0.026 [0.025e0.055] 0.03
Lactic acid bacteria 0.077 [0.026e0.235] 0.366 [0.006e0.586] 0.31
Faecalobacterium prausnitzii 28.78 [11.78e61.96] 93.6 [23.39e108.2] 104
Escherichia coli 0.188 [0.06e2.323] 0.127 [0.072e1.306] 0.87
Firmicutes/Bacteroidetes ratio 7.73 [3e11.38] 3.11 [1.3e5.81] 7.48
Faecalibacterium prausnitzii/
Escherichia coli ratio
101.04 [26.68e619.1] 106.98 [71.64e184.43] 213
Values are concentrations expressed as median [IQRs]. Statistically significant difference
No differences when comparing the four clusters were observed, with the exception of tw
prausnitzii. Also, only one difference was observed in Prevotella when comparing clu
prausnitzii and a small one in lactic acid bacteria when comparing clusters from the OB
NOB¼ non-obese, OB¼obese.
a Comparison among 4 clusters.
b Comparison between clusters 2 and 3.
c Comparison between clusters 5 and 6.than in any of the other clusters (p ¼ 0.052), and also a trend to-
wards differences in F.prausnitzii abundance were observed be-
tween clusters (p ¼ 0.059) (Table 3 and Supplementary Figure S2).
Within OB, those in the OB-5 cluster had a higher load of both lactic
acid bacteria (p ¼ 0.053) and F. prausnitzii (P ¼ 0.042) than subjects
in cluster OB-6. In contrast, within NOB, the NOB-2 cluster tended
to have a higher load of Prevotella than cluster NOB-3, but without
reaching statistical significance (P ¼ 0.073).
More similarities were observed between clusters NOB-3 and
OB-5 and between clusters NOB-2 and OB-6 than between clusters
within the same group (NOB-2 and NOB-3, OB-5 and OB-6).
3.3. T2D risk
3.3.1. Clusters
Once we observed the differences among the 4 clusters in terms
of dietary patterns and their effects on gut microbiota, we studied if
these differences might play a role in the risk of developing T2D.
The risk percentage of developing T2D varied among the four
clusters (p ¼ 0.005), however, the differences did not come from
comparisons between clusters within the same group (NOB-2 andcribed.
-5 (n¼8) OB -6 (n¼24) P-valuea P-valueb P-valuec
.1 [135.5e227.5] 146.1 [102.9e478.3] 0.960 0.625 0.902
4 [20.06e35.53] 37.61 [17.06e66.31] 0.585 0.454 0.418
5 [0.022e0.703] 0.052 [0.014e1.927] 0.052 0.073 0.902
[0.068e19.56] 0.056 [0.027e0.162] 0.292 0.819 0.053
.1 [54.44e189.9] 26.69 [11.36e79.25] 0.059 0.204 0.042
2 [0.328e10.32] 0.141 [0.033e1.862] 0.550 0.672 0.177
[3.76e19.085] 6.25 [2.065e18.3] 0.406 0.111 0.539
.02 [34.715e264.74] 175.59 [11.28e1525.895] 0.922 0.536 0.825
s are highlighted in boldface.
o differences found in the significance level limit for Prevotella and Faecalibacterium
sters from the NOB group. A significant difference was seen in Faecalibacterium
group.
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p ¼ 1000).
We then looked at the individuals classified as having a “high” or
“very high” risk of T2D and compared the clusters that were similar
in dietary patterns. We observed that NOB-3 and OB-5 presented a
similar T2D risk classification (p ¼ 0.19), therefore, despite the
difference in BMI, there was no greater risk of developing T2D in
the obese group. In contrast, comparing OB-6 to NOB-2 showed
more individuals in this “high” and “very high” T2D risk classifi-
cation (p ¼ 0.003), which means that obesity plays an important
role in T2D risk when the quality of diet and intestinal microbiota
are poorer.
In agreement with these results, we observed that insulinemia,
as well as the compensation of b-cell function measured by HOMA-
b, was not different between NOB-3 and OB-5 but was higher in OB-
6 with respect to NOB-2 (p ¼ 0.001, p ¼ 0.005 respectively).
4. Discussion
Obesity is associated with an array of health problems and its
prevalence clearly shows a gradual increase of impaired glucose
metabolism, a finding that supports the important role of obesity in
the development of T2D [11]. One particular study showed that an
increase in BMI raised the incidence of T2D by 25% in the general
population [12].
On the contrary, the relative risk of many diseases associated
with a greater BMI declines with age [20]. Nevertheless, absolute
mortality and health complications associated with obesity in-
crease linearly with a corresponding increase in BMI until the age
of 75 years [20]. Beyond the age of 80 years, the association be-
tween BMI and mortality becomes weakened, primarily because
the elderly may have a low body weight due to unintentional
weight loss, a common complication of many serious diseases,
which could confound the interpretation of weight loss effects on
mortality, and also due to sarcopenia, a decrease in lean mass
which often accompanies functional limitations and poor health
outcomes [21].
Obesity, even so, has a negative impact on older persons with an
impaired health status [22]. In particular, we found that T2D risk
also increases with obesity in the elderly, along with aworsening of
many parameters such as levels of glucose, HbA1c and insulin, but
also HOMA-IR and HOMA-b. With these results, we can also relate
an increased risk of developing other diseases associated with T2D
which are driven by the combination of insulin resistance and a
pro-inflammatory state [23], such as CVD [24].
The relation between energy intake and expenditure is an
important determinant of obesity. Therefore, the increase in total
fat mass that occurs with aging must be attributable to an increase
in energy intake, a decrease in energy expenditure, or both.
Physical activity reduces with age, and it has been estimated
that it accounts for about one-half of the decrease in total energy
expenditure that occurs with aging [25]. Therefore, it is likely that a
decrease in energy expenditure is an important contributor to the
gradual increase in body fat observed with age. Both groups in our
study were characterized by lower energy expenditure than found
in a group of people 60 years old described in a previous study
[26]. Also, we found that the OB group performed less physical
activity than the NOB group, in accordance with previous results in
which BMI was found to be inversely related to measured physical
performance in older persons [27].
In the last decade, sedentary behavior has emerged as a new risk
factor for health [28].
Findings from a study in the UK reported that objectively
measured sedentary time increased with age [29]. Indeed, our
study OB group spent more time performing sedentary activities,which has been associated with higher plasma glucose [26]. In
addition, excess body fat mass and a BMI of30 in older individuals
have been associated with physical dysfunction and are predictive
of a decline in functional status and future disability [30].
The elderly prediabetic population in our study showed an
elevated food intake in relation to daily energy expenditure. The
calories they ingested were higher than in a previous study per-
formed in the same region, Catalonia-Spain, in healthy individuals
aged between 65 and 75 years [31]. In addition, according to the
American Diabetes Association (ADA), healthy low-calorie eating
patterns should be recommended for patients at a high risk of
developing T2D [2].
The percentage of TCC from carbohydrates ingested by our
population did not exceed recommendations [18,19]. Nevertheless,
the percentage of TCC from simple sugars was above the recom-
mendations [18,19], which is described that, independently the
mechanisms by which the sugar intake might promote weight gain
by increasing energy consumption to an extent that exceeds energy
output and distorts energy balance [32], the increased consump-
tion of simple sugar increase hyperinsulinaemia [33]. In addition,
total fiber was less than previously described in same region pop-
ulation [30,34], and soluble fiber in particular was below the rec-
ommendations [35,36].
The percentage of TCC from lipids was higher than the recom-
mendations [34e36], but recent evidence suggests that quality of
fats is prior than quantity [37].In this regard, dietary patterns
characterized by a low intake of SFA and a higher intake of UFA are
protective and promote a beneficial effect on insulin sensitivity
[38]. In our study, comparing to recommendations, for both groups
ingested SFAwas greater [36], but amounts of MUFA and PUFAwere
close to it [35]. Specifically, the intake of PUFA u3, in particular,
linolenic acid, which have been associated to an improvement to
cardiovascular health [39,40], was higher in the NOB group.
Meanwhile, the intake of cholesterol was greater in the OB group,
exceeding the recommendations [35], which has been associated
with an increase in the incidence of CVD.
The quantity and also the percentage of TCC from proteins were
correct in both OB and NOB groups, but when taking body weight
into consideration, the OB showed lower intake than NOB group. A
modest increase in protein assists in achieving and maintaining
weight reduction and also helps to minimize loss of lean mass [36].
As for micronutrients, different parameters related to antioxi-
dant power consumed were lower for the OB group. Among them,
less intake of tocopherol, which a cross-sectional study found to
have an inverse correlation with fasting plasma insulin concen-
trations [41], luteine, which the same study found inversely
correlated with insulin resistance [42], and others such as organic
and citric acids, which are very present in plant-based foods. In fact,
green leafy vegetables, which are the most rich in these nutrients,
demonstrated a capacity to reduce the risk of developing T2D, as an
increased consumption of them was associated with a decrease in
the incidence of T2D [42].
Subsequently, two different dietary patterns were observed in
each group. Subgroups NOB-2 and OB-6 showed similar nutrient
intake patterns rich in amino acids and B-group vitamins, SFA and
MUFA, but pattern from the subgroup OB-6 was characterized to
involved also the consumption of PUFA u6, carbohydrates, and,
especially, simple sugar. Another similar nutrient intake pattern
was observed between subgroups NOB-3 and OB-5 characterized
by the consumption of PUFA u3, antioxidant nutrients, minerals
and purines, but while the former was rich in PUFA u6, the latter
was rich in B-group vitamins and some minerals.
The effect of obesity on elderly prediabetic subjects seems to not
have an impact on gutmicrobiota composition. Only Prevotella load,
previously associated with Mediterranean diet and plant-based
D.A. Díaz-Rizzolo et al. / Clinical Nutrition 39 (2020) 524e532530diets [43] and with a polyphenols-rich diet [44], was higher in NOB.
This is related to a higher consumption of PUFA and antioxidant
nutrients such as polyphenols [45], which corresponded to the
differences observed in nutrient intake between NOB and OB.
Previous studies have documented changes in the gut micro-
biota taken from subjects with obesity or certain dietary patterns
and analysed for bacterial load indicators. Since no major shifts in
gut microbiota have been observed in our cohort, our results could
suggest that in these population groups nutrient intake has a
stronger effect than obesity in modulating the composition of gut
microbiota.
Interestingly, differences were observed between clusters of
patients based on dietary patterns. Prevotella was found to be
especially elevated in the NOB-2 cluster following a more un-
healthy diet. These bacteria have been found in elevated concen-
trations in T2D patients [46] and in prediabetic populations
following a diet rich in fat and protein [47]. But, on the other hand,
this genus has been positively correlated with a higher consump-
tion of oleic acid and inversely correlated with animal protein and
animal fats [48]. Concretely, Prevotella is link with the Mediterra-
nean diet probably due to consuming plant-foods rich in lipids of
the MUFA type, such as olive oil and nuts, while the amino acid and
SFA dietary patterns probably indicate a non-animal origin, thereby
creating similarities with the dietary patterns found in the NOB-2
group.
Prevotella appeared even slightly higher in the OB-6 cluster, but
the reason for this could also be due to a diet rich in carbohydrates
and simple sugars [49], suggesting that high proportions of these
bacteria can lead to obesity in high-caloric Western diets [50]. This
could explain the lower load of lactic acid bacteria found in this
cluster in comparison with OB-5, due to the dietary patterns of OB-
6 should be linked withWestern diets rich in animal protein and fat
and low in fibre which have demonstrated a decrease in these
bacteria load [51]. In contrast, the OB-5 cluster shows a very high
load of lactic acid bacteria, which has been related with a fish-oil
rich diet in mice [52] and can be linked to the dietary pattern of
this cluster through PUFAu3. A high load of this bacterial group has
also been observed in a lactose-rich diet [53], which can be also
linked to the presence of vitamin B2 and specific minerals such as
calcium and iron, among others, in this cluster. Different lactic acid
bacteria have been related with an improvement in glucose
metabolism and a reduction in chronic inflammation [54] and have
been found in reduced quantities in patients with T2D and obesity
[55]. Finally, F. prausnitzii was higher in NOB-3 and OB-5. The di-
etary patterns of both subgroups were rich in PUFA u3, antioxidant
nutrients and were compounded for the same minerals and pu-
rines. These results can be linked with previously studies where an
increase in these bacteria was found due to a diet rich in fruit, le-
gumes and some vegetables [56e58]. Also, F. prausnitzii has been
demonstrated to decrease with hydrolysed complex carbohydrates
[59], which could translate into the carbohydrates appearing in the
dietary pattern of OB-6 that come from simple carbohydrates found
in ultra-processed foods [60]. A possible association between
changes in this species of bacteria and insulin sensitivity has been
previously suggested [61e63], and depletion of this species has
been reported in patients with T2D [64e66]. Supporting the in-
fluence of F. prausnitzii on T2D, a study analysing F. prausnitzii
profiles in obese subjects with and without T2D has suggested that
differences in this species phylotypes may lead to differences in
inflammatory status in the host, thus having an influence on dis-
ease development [65]. Furthermore, its anti-inflammatory prop-
erties have been consistently demonstrated [66].
We have shown in our study that individuals from a specific
group of elderly people with preDM and obesity present a higher
risk of developing T2D and worse metabolic outcomes. However, inthose individuals who present a healthier dietary pattern and gut
microbiota, the presence of obesity does not appear to modify
insulinemia or the compensatory function of b cells, nor does it
increase the risk of developing T2D.
Therefore, we can conclude that a healthy dietary pattern and
the growth-promoting beneficial and growth-inhibiting disadvan-
tageous gut microbiota populations linked to it provide protection
against the development of T2D in an obese population with
advanced age and preDM.Clinical trial
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